Courneya KS, Friedenreich CM. Designing, analyzing, and interpreting observational studies of physical activity and cancer outcomes from a clinical oncology perspective. Front Oncol. 2023;13:1098278.
Google Scholar
Courneya KS, Booth, CM. Exercise as a cancer treatment: a clinical oncology framework for exercise oncology research. Front Oncol. 2022;12:957135.
Courneya KS, McNeely ML, Booth CM, Friedenreich CM. An integrated framework for the study of exercise across the postdiagnosis cancer continuum. Front Oncol. 2024;14:1432899.
Google Scholar
Masuda H, Harano K, Miura S, Wang Y, Hirota Y, Harada O, et al. Changes in triple-negative breast cancer molecular subtypes in patients without pathologic complete response after neoadjuvant systemic chemotherapy. JCO Precis Oncol. 2022;6:e2000368.
Google Scholar
Topham JT, O’Callaghan CJ, Feilotter H, Kennecke HF, Lee YS, Li W, et al. Circulating tumor DNA identifies diverse landscape of acquired resistance to anti-epidermal growth factor receptor therapy in metastatic colorectal cancer. J Clin Oncol. 2023;41:485–96. JCO2200364.
Ashcraft KA, Peace RM, Betof AS, Dewhirst MW, Jones LW. Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data. Cancer Res. 2016;76:4032–50.
Google Scholar
Yang L, Morielli AR, Heer E, Kirkham AA, Cheung WY, Usmani N, et al. Effects of exercise on cancer treatment efficacy: a systematic review of preclinical and clinical studies. Cancer Res. 2021;81:4889–95.
Google Scholar
Francis S, Orton A, Stoddard G, Tao R, Hitchcock YJ, Akerley W, et al. Sequencing of postoperative radiotherapy and chemotherapy for locally advanced or incompletely resected non-small-cell lung cancer. J Clin Oncol. 2018;36:333–41.
Google Scholar
Ma TM, Sun Y, Malone S, Roach M, 3rd, Dearnaley D, Pisansky TM, et al. Sequencing of androgen-deprivation therapy of short duration with radiotherapy for nonmetastatic prostate cancer (SANDSTORM): a pooled analysis of 12 randomized trials. J Clin Oncol. 2023;41:881–92. JCO2200970.
Friedenreich CM, Wang Q, Neilson HK, Kopciuk KA, McGregor SE, Courneya KS. Physical activity and survival after prostate cancer. Eur Urol. 2016;70:576–85.
Google Scholar
Friedenreich CM, Courneya KS, Bryant HE. The lifetime total physical activity questionnaire: development and reliability. Med Sci Sports Exerc. 1998;30:266–74.
Google Scholar
Friedenreich CM, Courneya KS, Neilson HK, Matthews CE, Willis G, Irwin M, et al. Reliability and validity of the past year total physical activity questionnaire. Am J Epidemiol. 2006;163:959–70.
Google Scholar
De Vera MA, Ratzlaff C, Doerfling P, Kopec J. Reliability and validity of an internet-based questionnaire measuring lifetime physical activity. Am J Epidemiol. 2010;172:1190–8.
Google Scholar
Torres ER. Validation of the lifetime total physical activity questionnaire (LTPAQ) in midlife and older adults with a history of late-onset depression. Arch Psychiatr Nurs. 2018;32:580–4.
Google Scholar
Webber M, Li M, Cai C, Zou K. Effects of exercise training on prostate cancer: current evidence and potential molecular mechanisms. Adv Exercise and Health Sci. 2024;3:160–169.
Stagaard R, Jensen A, Schauer T, Bay ML, Tavanez AR, Wielsoe S, et al. Exercise boost after surgery improves survival in model of metastatic breast cancer. Front Immunol. 2025;16:1533798.
Google Scholar
Friedenreich CM, Stone CR, Cheung WY, Hayes SC. Physical activity and mortality in cancer survivors: a systematic review and meta-analysis. JNCI Cancer Spectr. 2020;4:pkz080.
Google Scholar
Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, et al. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomark Prev. 2015;24:57–64.
Google Scholar
Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29:726–32.
Google Scholar
Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the Cancer of the Prostate Strategic Urologic Research Endeavour. Cancer Res. 2011;71:3889–95.
Google Scholar
Wang Y, Jacobs EJ, Gapstur SM, Maliniak ML, Gansler T, McCullough ML, et al. Recreational physical activity in relation to prostate cancer-specific mortality among men with nonmetastatic prostate cancer. Eur Urol. 2017;72:931–9.
Google Scholar
Lee M, Lee Y, Jang D, Shin A. Physical activity after colorectal cancer diagnosis and mortality in a nationwide retrospective cohort study. Cancers. 2021;13:4804.
Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al. NCCN clinical practice guidelines in oncology: prostate cancer. Version 4. 2024. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2024. [cited 2024 Nov 25]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459
Rodrigues M, Wong WW, Boorjian SA. Clinically localized prostate cancer: AUA/ASTRO guideline 2022. Linthicum (MD): American Urological Association; 2022. Available from: https://www.auanet.org/guidelines-and-quality/guidelines/clinically-localized-prostate-cancer-aua/astro-guideline-2022
Nini A, Gandaglia G, Fossati N, Suardi N, Cucchiara V, Dell’Oglio P, et al. Patterns of clinical recurrence of node-positive prostate cancer and impact on long-term survival. Eur Urol. 2015;68:777–84.
Google Scholar
Roy S, Sun Y, Eastham JA, Gleave M, Beltran H, Kishan AU, et al. Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs). Am Soc Clin Oncol. 2025;43:309
link